news

« BACK

Pharmacology



Results 1 - 3 of 3.


Health - Pharmacology - 05.06.2025
Reduced antimicrobial resistance in E. coli cases
Study marks a significant milestone in the ongoing battle against antimicrobial resistance, a global public health threat A new groundbreaking large-scale research study from University of Limerick marks a major milestone in the battle against antimicrobial resistance (AMR), a global public health threat that could add a trillion US dollars to worldwide healthcare costs over the next 25 years.

Health - Pharmacology - 28.04.2025
BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation
BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation
New findings suggest the vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral infections by reprogramming innate immune cells to regulate inflammation Trinity researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target.

Health - Pharmacology - 23.08.2024
New obesity treatments could speed up metabolism, finds clinical trial
New obesity treatments could speed up metabolism, finds clinical trial
Weight-loss medications such as Ozempic, Wegovy or Monjaro may not just suppress appetite but could also speed up metabolism. This is according to a new study carried out at St Vincent's University Hospital (SVUH) . A randomized controlled trial led by Professor Donal O'Shea , SVUH and UCD School of Medicine , found that there was a strong relationship between the amount of weight lost and increases in metabolic activity caused by daily use of medications based on the hormone Glucagon-like peptide-1 (GLP-1).